Interdisciplinary collaboration is key to reducing the risk for osteonecrosis of the jaw and improving patient care.

A new study reveals that iSN40 also inhibits osteoclastogenesis, reducing bone resorption. By modulating both bone formation and resorption, iSN40 offers a potential new approach for the treatment ...

Yamada et al. evaluated the performance of serum tartrate-resistant acid phosphatase 5b (TRACP5b), a biochemical marker for bone resorption, in comparison with established markers in the ...